Subgroups | No. of studies | No. of patients | Effects model | HR (95%CI) | p | Heterogeneity I2(%) Ph | |
---|---|---|---|---|---|---|---|
OS | |||||||
 Total | 5 | 2125 | Fixed | 1.43(1.20–1.71) |  < 0.001 | 48.8 | 0.098 |
Sample size | |||||||
 < 200 | 2 | 331 | Random | 2.86(0.93–8.83) | 0.067 | 64.9 | 0.091 |
 ≥ 200 | 3 | 1794 | Fixed | 1.28(1.05–1.57) | 0.016 | 0 | 0.921 |
TNM stage | |||||||
 I-IV | 3 | 1017 | Random | 1.84(0.74–4.61) | 0.192 | 62.4 | 0.070 |
 I-III/II-III/II-IV | 2 | 1108 | Random | 1.52(1.07–2.14) | 0.018 | 59.6 | 0.116 |
Treatment | |||||||
 Surgery | 4 | 1933 | Fixed | 1.33(1.09–1.62) | 0.005 | 44.2 | 0.146 |
 Radiotherapy/CRT + ICIs | 1 | 192 | - | 1.88(1.28–2.75) | 0.001 | - | - |
SIRI cut-off value | |||||||
 < 1.0 | 2 | 878 | Fixed | 1.20(0.78–1.83) | 0.408 | 0 | 0.871 |
 ≥ 1.0 | 3 | 1247 | Random | 1.80(1.09–2.95) | 0.020 | 71.2 | 0.031 |
Survival analysis | |||||||
 Univariate | 1 | 139 | - | 6.26(1.63–24.01) | 0.008 | - | - |
 Multivariate | 4 | 1986 | Fixed | 1.39(1.17–1.67) |  < 0.001 | 3.7 | 0.374 |
PFS | |||||||
 Total | 2 | 243 | Fixed | 2.00(1.35–2.98) | 0.001 | 0 | 0.409 |